These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
192 related articles for article (PubMed ID: 19595402)
61. Drug-eluting stent thrombosis after cilostazol withdrawal in a patient previously treated with triple antiplatelet therapy. Im E; Lee SH; Kim JS; Choi D; Jang Y Int J Cardiol; 2009 Jun; 135(2):e55-7. PubMed ID: 18582963 [TBL] [Abstract][Full Text] [Related]
62. The saga of the duration of dual antiplatelet therapy after drug-eluting stent placement. Helft G Arch Cardiovasc Dis; 2015 Oct; 108(10):469-71. PubMed ID: 26432274 [No Abstract] [Full Text] [Related]
63. Very Late Stent Thrombosis 11 Years after Implantation of a Drug-Eluting Stent. Liou K; Jepson N Tex Heart Inst J; 2015 Oct; 42(5):487-90. PubMed ID: 26504449 [TBL] [Abstract][Full Text] [Related]
64. Emergent coronary artery bypass grafting for cardiogenic shock caused by very late drug-eluting stent thrombosis. Boffini M; Ceresa F; Sansone F; Ribezzo M; Comoglio C; Rinaldi M Gen Thorac Cardiovasc Surg; 2009 Nov; 57(11):609-11. PubMed ID: 19908116 [TBL] [Abstract][Full Text] [Related]
65. Five-year clinical follow-up after implantation of the Endeavor zotarolimus-eluting stent: ENDEAVOR I, first-in-human study. Meredith IT; Ormiston J; Whitbourn R; Kay IP; Muller D; Cutlip DE; Catheter Cardiovasc Interv; 2009 Dec; 74(7):989-95. PubMed ID: 19859958 [TBL] [Abstract][Full Text] [Related]
66. Recurrence of late-acquired incomplete stent apposition following sirolimus-eluting stent implantation. Iwata H; Ako J; Nagai R J Invasive Cardiol; 2008 Sep; 20(9):E265-8. PubMed ID: 18762685 [TBL] [Abstract][Full Text] [Related]
67. Late angiographic stent thrombosis: the LAST straw for drug-eluting stents? Chen JP; Crisco LV; Jabara R; King SB Angiology; 2008 Dec-2009 Jan; 59(6):667-75. PubMed ID: 18388045 [TBL] [Abstract][Full Text] [Related]
68. [Late thrombosis after bare metal stent implantation in a patient with acute coronary syndrome]. Chyrchel M; Rzeszutko Ł; Rakowski T; Chyrchel B; Dudek D Kardiol Pol; 2008 Mar; 66(3):316-9, discussion 320-1. PubMed ID: 18393118 [TBL] [Abstract][Full Text] [Related]
70. Late angiographic stent thrombosis (LAST): the cloud behind the drug-eluting stent silver lining? Chen JP J Invasive Cardiol; 2007 Sep; 19(9):395-400. PubMed ID: 17827510 [TBL] [Abstract][Full Text] [Related]
71. [Role of bare metal stent in drug eluting stent era]. Takizawa K; Inoue N Nihon Rinsho; 2011 Feb; 69(2):265-70. PubMed ID: 21387674 [TBL] [Abstract][Full Text] [Related]
72. Real polymer-free sirolimus- and probucol-eluting versus biodegradable polymer sirolimus-eluting stents for obstructive coronary artery disease: DKPLUS-Wave 1, a multicenter, randomized, prospective trial. Chen SL; Ye F; Zhang JJ; Zou JJ; Qian XS; Li F; Yang S; Ge Z; Shan SJ; Li XB; Xu T; Kan J; Lin L; Han YL Cardiovasc Ther; 2013 Aug; 31(4):193-200. PubMed ID: 22954234 [TBL] [Abstract][Full Text] [Related]
73. Stent thrombosis after percutaneous coronary intervention for bifurcation lesions. Tan HC J Interv Cardiol; 2009 Apr; 22(2):114-6. PubMed ID: 19379468 [TBL] [Abstract][Full Text] [Related]
74. The risk of cardiac complications following noncardiac surgery in patients with drug eluting stents implanted at least six months before surgery. Assali A; Vaknin-Assa H; Lev E; Bental T; Ben-Dor I; Teplitsky I; Brosh D; Fuchs S; Eidelman L; Battler A; Kornowski R Catheter Cardiovasc Interv; 2009 Nov; 74(6):837-43. PubMed ID: 19626693 [TBL] [Abstract][Full Text] [Related]
75. Incidence, predictors and outcome of drug-eluting stent thrombosis in real-world practice. Blich M; Zeidan-Shwiri T; Petcherski S; Osherov A; Hammerman H J Invasive Cardiol; 2010 Oct; 22(10):461-4. PubMed ID: 20944183 [TBL] [Abstract][Full Text] [Related]
76. [Care of patients after coronary stent implantation: what is important in practice?]. Schächinger V Internist (Berl); 2007 Dec; 48(12):1365-74. PubMed ID: 17992495 [TBL] [Abstract][Full Text] [Related]
77. Stent underexpansion in early drug-eluting stent thrombosis. Kaneda H; Ma J; Morita T JACC Cardiovasc Interv; 2009 Aug; 2(8):807. PubMed ID: 19695553 [No Abstract] [Full Text] [Related]
78. Very late stent thrombosis after drug-eluting stent in segment with neointimal tissue coverage. Nishiguchi T; Kitabata H; Tanaka A; Kataiwa H; Ishibashi K; Komukai K; Tanimoto T; Ino Y; Takarada S; Kubo T; Nakamura N; Mizukoshi M; Imanishi T; Akasaka T JACC Cardiovasc Imaging; 2010 Apr; 3(4):445-6. PubMed ID: 20394907 [No Abstract] [Full Text] [Related]
79. Acute promyelocytic leukemia as a cause of intracoronary drug-eluting-stent thrombosis. Sargsyan Z; Higgins C; Alexandrescu S; Ott DA; Jain SK Tex Heart Inst J; 2012; 39(3):416-9. PubMed ID: 22719158 [TBL] [Abstract][Full Text] [Related]
80. [A case of recurrent stent thrombosis in a drug-eluting stent following antiplateled therapy discontinuation]. Wożakowska Kapłon B; Jaskulska Niedziela E; Niedziela J; Gutkowski W Kardiol Pol; 2011; 69(6):621-3; discussion 624. PubMed ID: 21678309 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]